Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Lung Neoplasms 4Breast Neoplasms 4Motor Activity 3Rehabilitation 2Carcinoma, Non-Small-Cell Lung 2Sleep Initiation and Maintenance Disorders 1Sarcoma 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Pancreatic Diseases 1Pain, Postoperative 1Myelodysplastic Syndromes 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Leukemia, Myeloid, Acute 1Fatigue 1Dyspnea 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Breast Cancer Lymphedema 1Brain Neoplasms 1Anaplasia 1Agnosia 1Advanced Cancer 1

Interventions

Nivolumab 20Ipilimumab 10Paclitaxel 7linrodostat 6Standard of Care 6Sirolimus 5Gemcitabine 5Bevacizumab 5temsirolimus 4relatlimab 4Pemetrexed 4Docetaxel 4Carboplatin 4ARRY-334543 4Vorinostat 3Erlotinib Hydrochloride 3Dasatinib 3Cetuximab 3regorafenib 2olaparib 2apatinib 2anlotinib 2abemaciclib 2Trastuzumab 2Surveys and Questionnaires 2Sunitinib 2Sorafenib 2Olanzapine 2N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Cancer × Rehabilitation × Clear all
NCT07133269 2026-02-12

Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients

Singapore General Hospital

Phase NA Recruiting
770 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡